Mom Notices Daughter Has Extreme Thirst – Then Comes Devastating Diagnosis

The disease gradually takes away the skills children have learned—leading to seizures, movement difficulties and profound ...

FDA Extends Review of DNLI's Hunter Syndrome Drug by Three Months

Denali Therapeutics faces an FDA review delay for its Hunter syndrome drug, pushing potential approval of tividenofusp alfa to April 2026.

Spruce Biosciences Announces $50.0 Million Private Placement Financing

Detailed price information for Spruce Biosciences Inc (SPRB-Q) from The Globe and Mail including charting and trades.
Investor's Business Daily on MSN

Stock Market Mixed, But AMD, Nvidia, Taiwan Semi Lift AI; Tesla Launches Stripped-Down EVs: Weekly Review

The stock market was mixed, with AMD and Nvidia lifting the S&P 500 and Nasdaq to highs while the Dow Jones fell. Tesla ...
Proactive Investors

Nasdaq and S&P 500 close at record levels, boosted by...Nasdaq and S&P 500 close at record levels, boosted by AMD-OpenAI deal as bitcoin and gold hit...

Investors brush off shutdown It was a mixed day for US stocks, with the S&P 500 and Nasdaq closing at record levels as the ...
Benzinga.com

FDA Calendar

HUTCHMED (China) Limited announces results from the FRUSICA-2 registration clinical trial of the fruquintinib and sintilimab combination for the treatment of patients with locally advanced or ...